Align Technology logo
Align Technology ALGN
$ 166.87 -2.91%

Quarterly report 2025-Q3
added 11-05-2025

report update icon

Align Technology Financial Statements 2011-2026 | ALGN

Annual Financial Statements Align Technology

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

13.9 B 23.1 B 23.9 B 51.9 B 42.1 B 20.9 B 18.6 B 21.6 B 7.19 B 5.29 B 4.28 B 4.71 B 2.36 B 1.98 B

Shares

74.9 M 76.4 M 78.2 M 78.9 M 78.8 M 79.4 M 80.1 M 80.1 M 79.9 M 80 M 80.8 M 80.6 M 80.5 M 78 M

Historical Prices

186 303 306 657 534 279 209 222 96.1 65.8 55.9 57.1 27.8 23.7

Net Income

421 M 445 M 362 M 772 M 1.78 B 443 M 400 M 231 M 190 M 144 M 146 M 64.3 M 58.7 M 66.7 M

Revenue

4 B 3.86 B 3.73 B 3.95 B 2.47 B 2.41 B 1.97 B 1.47 B 1.08 B 845 M 762 M 660 M 560 M 480 M

Cost of Revenue

1.2 B 1.16 B 1.1 B 1.02 B 709 M 663 M 519 M 356 M 265 M 205 M 183 M 162 M 144 M 118 M

Gross Profit

2.8 B 2.71 B 2.63 B 2.94 B 1.76 B 1.74 B 1.45 B 1.12 B 815 M 640 M 578 M 498 M 416 M 361 M

Operating Income

608 M 643 M 643 M 976 M 387 M 542 M 467 M 354 M 249 M 189 M 194 M 94.2 M 85.6 M 90.4 M

Interest Expense

- - - - - 7.68 M -8.49 M 11.2 M -6.36 M -2.53 M -3.21 M -1.07 M -2.05 M 51 K

EBITDA

753 M 786 M 768 M 1.09 B 481 M 593 M 521 M 391 M 273 M 207 M 211 M 178 M 126 M 92.8 M

Operating Expenses

2.19 B 2.06 B 1.99 B 1.96 B 1.38 B 1.23 B 981 M 763 M 566 M 451 M 385 M 337 M 294 M 271 M

General and Administrative Expenses

1.76 B 1.7 B 1.67 B 1.71 B 1.2 B 1.07 B 852 M 666 M 491 M 390 M 115 M 113 M 95.8 M 89.2 M

All numbers in USD currency

Quarterly Income Statement Align Technology

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

72.4 M 72.6 M 73.6 M 73.8 M 74.7 M 75.2 M 75.2 M 75.1 M 76.6 M 76.5 M 76.9 M 77.3 M 78.1 M 78.4 M 78.7 M 78.7 M 78.9 M 79 M 79 M 78.9 M 78.8 M 78.8 M 78.6 M 78.4 M 79.3 M 79.9 M 79.9 M 79.8 M 80.1 M 80.2 M 80 M 80 M 80.2 M 80.2 M 79.9 M 79.6 M 80 M 80 M 79.8 M 79.5 M 79.8 M 80.3 M 80.5 M 80.2 M 80.6 M 81 M 81.1 M 80.6 M 80 M 80.6 M 81.2 M 80.6 M 81.4 M 80.4 M 79.2 M 78.8 M 78.5 M 77.9 M 76.8 M

Net Income

56.8 M 125 M 93.2 M - 116 M 96.6 M 105 M - 121 M 112 M 87.8 M - 72.7 M 113 M 134 M - 181 M 200 M 200 M - 139 M -40.6 M 1.52 B - 103 M 147 M 71.8 M - 101 M 106 M 95.9 M - 82.6 M 69.2 M 69.4 M - 51.4 M 50.1 M 40.5 M - 27.6 M 31.4 M 36.2 M - 38.2 M 35.6 M 32.4 M - 34.5 M 29.3 M -42 M - -344 K 28.5 M 21 M - 19.3 M 11.2 M 15.8 M

Revenue

996 M 1.01 B 979 M - 978 M 1.03 B 997 M - 960 M 1 B 943 M - 890 M 970 M 973 M - 1.02 B 1.01 B 895 M - 734 M 352 M 1.99 M - 3.48 M 3.46 M 2.63 M - 2.23 M 1.92 M 2.18 M - 1.83 M 1.44 M 1.2 M - 279 M 269 M 239 M - 208 M 209 M 198 M - 190 M 193 M 181 M - 165 M 164 M 154 M - 136 M 146 M 135 M - 126 M 120 M 105 M

Cost of Revenue

356 M 304 M 299 M - 296 M 306 M 300 M - 297 M 289 M 282 M - 271 M 282 M 264 M - 261 M 252 M 218 M - 200 M 128 M 157 M - 170 M 168 M 147 M - 134 M 125 M 110 M - 92.8 M 85.6 M 74.7 M - 69.4 M 64.1 M 58.1 M - 50.1 M 50.9 M 47 M - 44.8 M 47.1 M 43.4 M - 39.4 M 40.1 M 40.7 M - 36.1 M 36.8 M 34.3 M - 33.5 M 28.9 M 22.6 M

Gross Profit

639 M 708 M 680 M - 682 M 723 M 698 M - 663 M 714 M 661 M - 619 M 688 M 709 M - 755 M 759 M 677 M - 534 M 224 M 394 M - 438 M 432 M 402 M - 372 M 366 M 327 M - 292 M 271 M 236 M - 209 M 205 M 181 M - 158 M 159 M 151 M - 145 M 145 M 137 M - 125 M 124 M 113 M - 100 M 109 M 101 M - 92.4 M 91.1 M 82.2 M

Operating Income

96.3 M 163 M 131 M - 162 M 147 M 154 M - 166 M 172 M 134 M - 144 M 188 M 198 M - 261 M 269 M 225 M - 177 M -73 M 69.9 M - 127 M 176 M 87.7 M - 125 M 123 M 98.2 M - 98.8 M 83.6 M 61.7 M - 62.1 M 65.1 M 53.3 M - 38 M 42.3 M 48.9 M - 51.5 M 48.7 M 41.8 M - 41.5 M 37.9 M -38.1 M - 4.5 M 36 M 28 M - 26.3 M 16.6 M 21 M

EBITDA

152 M 204 M 170 M - 200 M 183 M 187 M - 203 M 208 M 169 M - 176 M 218 M 228 M - 289 M 295 M 251 M - 202 M -49.5 M 90.7 M - 147 M 196 M 106 M - 139 M 135 M 110 M - 109 M 92.4 M 69.5 M - 69 M 70.2 M 58.1 M - 51.2 M 51 M 53.2 M - 65 M 57.9 M 46.6 M - 54.1 M 46.7 M -33.1 M - 17 M 41.9 M 30.8 M - 35.4 M 22.7 M 24 M

Operating Expenses

543 M 545 M 549 M - 519 M 576 M 544 M - 497 M 542 M 527 M - 476 M 499 M 511 M - 494 M 490 M 452 M - 357 M 297 M 324 M - 310 M 256 M 314 M - 247 M 243 M 229 M - 194 M 187 M 174 M - 147 M 140 M 127 M - 120 M 116 M 102 M - 93.5 M 96.7 M 95.4 M - 83.6 M 85.8 M 151 M - 95.8 M 72.8 M 72.8 M - 66.1 M 74.5 M 61.2 M

General and Administrative Expenses

418 M 449 M 448 M - 434 M 452 M 452 M - 408 M 453 M 440 M - 399 M 426 M 439 M - 428 M 432 M 397 M - 312 M 257 M 283 M - 278 M 268 M 247 M - 214 M 212 M 200 M - 170 M 163 M 151 M - 127 M 121 M 112 M - 102 M 101 M 88.3 M - 28.3 M 27.1 M 29.2 M - 27.5 M 27 M 30.3 M - 24.8 M 23 M 23.5 M - 21.6 M 26.1 M 19 M

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Align Technology ALGN
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Align Technology plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
Globus Medical Globus Medical
GMED
$ 90.0 1.58 % $ 12.2 B usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 11.94 -1.08 % $ 1.61 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 1.83 -3.68 % $ 1.11 M usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 9.33 0.21 % $ 719 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 9.07 -3.3 % $ 257 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 36.67 -0.19 % $ 5.46 K usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.03 3.35 % $ 17.4 M usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 85.11 -0.61 % $ 2.96 B usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 15.76 -1.13 % $ 370 M usaUSA
LENSAR LENSAR
LNSR
$ 5.63 -4.41 % $ 67.3 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Medtronic PLC Medtronic PLC
MDT
$ 86.42 0.15 % $ 111 B usaUSA
FONAR Corporation FONAR Corporation
FONR
$ 18.58 -0.11 % $ 122 M usaUSA
Myomo Myomo
MYO
$ 0.68 -3.62 % $ 28.5 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 3.4 -1.73 % $ 127 M franceFrance
Orthofix Medical Orthofix Medical
OFIX
$ 11.71 -0.51 % $ 464 M curacaoCuracao
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
AxoGen AxoGen
AXGN
$ 30.99 -5.06 % $ 1.43 B usaUSA
Insulet Corporation Insulet Corporation
PODD
$ 202.46 -0.51 % $ 14.2 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Sintx Technologies Sintx Technologies
SINT
$ 2.66 5.14 % $ 7.38 M usaUSA
Smith & Nephew plc Smith & Nephew plc
SNN
$ 31.73 -2.74 % $ 23.8 B britainBritain
Stryker Corporation Stryker Corporation
SYK
$ 332.07 -0.1 % $ 127 B usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
$ 24.05 -2.12 % $ 550 M usaUSA
Butterfly Network Butterfly Network
BFLY
$ 4.05 -1.94 % $ 857 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Tandem Diabetes Care Tandem Diabetes Care
TNDM
$ 18.28 -4.64 % $ 1.24 B usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.61 3.37 % $ 38 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Delcath Systems Delcath Systems
DCTH
$ 9.67 -0.31 % $ 346 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 61.86 -1.17 % $ 91.6 B usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 11.03 0.55 % $ 1.66 B usaUSA
Varex Imaging Corporation Varex Imaging Corporation
VREX
$ 10.59 0.28 % $ 438 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 34.54 1.35 % $ 1.07 B usaUSA
Beyond Air Beyond Air
XAIR
$ 0.71 0.14 % $ 48.1 M usaUSA